IL17A and rheumatoid arthritis: Nakano et al. [47] have shown that, in RA synovial/SCID mouse chimera model, a selective D2-like receptor antagonist haloperidol significantly induces accumulation of IL-6+ and IL-17+ T cells with exacerbated cartilage destruction.